Loading company…
Teewinot Life Sciences develops cannabinoid pharmaceutical therapies through biosynthetic processes and chemical synthesis.
Teewinot Life Sciences Corporation produces and develops cannabinoid pharmaceutical therapies using biosynthetic processes and chemical synthesis. Founded in 2015 and based in Tampa, US, the company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in